Just! State Health and Health Commission issued a document strictly controlling hospital medication

today (June 9), the National Health and Care Commission issued a Notice on the Collection of 2019 Performance Review Data for Second and Third Levels Public HospitalsAccording to the notice, each three-level public hospital should log on to the public hospital performance appraisal management platform from June 12 to June 19, 2020 to report the dataThe provincial health and health committees shall complete the online audit of the data filled in by the tertiary public hospitals by June 26, 2020 to ensure the authenticity and integrity of the data reported by the hospitalsecondary public hospitals participating in the 2019 performance appraisal should report data on the management platform from July 20 to August 5, 2020The provincial health and health committees shall complete the online audit of the data filled in by the second-level public hospitals by September 6, 2020, so as to ensure the authenticity and integrity of the data reported by the hospitalExcept for the special instructions, the annual data in the quantitative indicators are provided for the year from 1 January to 31 December of that yearnotice is clear, it is strictly prohibited to fabricate, falsely report, underreport data and other circumstancesThe National Health and Health Commission will work with the relevant departments to organize experts to review and analyze the data, and seriously deal with the units and individuals that have deliberately fabricated, misrepresented, concealed and other violations of discipline in the course of the examinationfrom the National Health and Care Commission issued the second- and third-level hospital public hospital performance appraisal operation manual (2020 version), all mentioned the requirements of the proportion of drug revenuethe National Second-level Public Hospital Performance Assessment Manual (2020) requires that secondary hospitals should count "key monitoring drug revenue ratio":the "National Third-level Public Hospital Performance Assessment Operation Manual (2020)" requirements, tertiary hospitals to statistics "Auxiliary drug revenue ratio":although one is the focus of monitoring drugs, one is auxiliary drug use, but in fact the contents of these two statistics are the same, are for the provinces in the first batch of national key monitoring reasonable drug catalog on the basis of the provincial key monitoring reasonable drug catalog, the provincial key monitoring reasonable drug catalogfrom this point of view, the range of varieties of hospital performance appraisal statistics in different provinces may be differentJuly 1, 2019, the State Health and Care Commission officially released the "First batch of State key state key monitoring and rational drug use of drugs catalog (chemical drugs and biological products)." According to the notice, in order to implement the Opinions of the General Office of the State Council on Strengthening the Performance Evaluation of Three-Level Public Hospitals and the Notice of the National Health And Health Administration on The Management of Clinical Application of Complementary Drugs, the National Health and Health Administration, together with the State Administration of Traditional Chinese Medicine, has formed the first batch of national key monitoring catalogues on the basis of the provincial recommended catalogues submitted by various localitiesthrough the above content we can find that the first batch of national key monitoring catalog and auxiliary drug catalog has a certain connection, but it is not the same as auxiliary drug catalogSales of these 20 varieties in China's public hospitals totalled 65.28 billion yuan in 2018, according to the Minnet.com databaseBut the first batch of national key monitoring catalogues will not be officially launched until July 2019, and it is not good to say how much the size of these varieties can go in 2019in addition,, according to the "Notice of the Leading Group of the State Council on Deepening the Reform of the Medical and Health System" issued by the State Council on November 15, 2019, on further promoting the experience of deepening the reform of the medical and health system in Fujian Province and Sanming City, it is clearly requested that by the end of December 2019, provinces should formulate and issue a catalogue of provincial-level key drug monitoring (chemical and biological products) and publish a comprehensive mechanism for the control of key drugs by the end of December 2020from this point of view, the provinces issued a key monitoring directory of the time is different, statistics out of the focus of monitoring drugs / auxiliary drug revenue ratio is estimated to be differentbut there is one thing worthy of attention, the state to strengthen the clinical application management of complementary drug use, is to implement the task of deepening the reform of the medical and health system, control the unreasonable growth of medical expenses in public hospitals, but also to reduce the burden of patients to see a doctor, safeguard the people's health rights and interests of an important measureThis requirement is not temporary, but will be so strict, strict control of reasonable drug use and medical insurance feesthe National Health and Health Commission also released the "First batch of state key monitoring and rational drug use of drugs catalog (chemical drugs and biological products)" when, said that it will work with the State Administration of Traditional Chinese Medicine on the "catalogue" dynamic adjustmentdidn't find you this year, next year may not beis also on June 9, the National Health and Care Commission issued "on the new situation to do a good job in the management of the clinical application of antimicrobial drugs notice (draft for comments) public consultation announcement."comments from the optimization of the supply of antimicrobial drugs catalog, strengthen the management of key links and other aspects, continue to promote the rational use of antimicrobial drugsoptimize the list of antimicrobial drug supply, medical institutions are required to optimize the antimicrobial supply catalogue in the context of the "1 plus X" drug use model dominated by essential drugs ("1" is the national list of essential drugs, "X" is non-essential drugs)When formulating the catalogue and prescription set of antimicrobial drugs supply of this institution, in addition to ensuring the specifications of the varieties in accordance with the provisions, the selection of similar drugs shall be selected with safe, effective, economical and evidence-based varietiesstrengthen the management of key links, we should continue to promote the management of key antimicrobial drugs, focusing on preventive use, joint use and intravenous infusion, intrauterine injection, joint injection of antimicrobial drugsConditional medical institutions are encouraged to carry out monitoring of the concentration of therapeutic drugs for key antimicrobial drugs and guide clinical precision drug usethat is, in addition to the above-mentioned focus monitoring catalog, in the future every hospital will have to select the hospital's antimicrobial supply catalog, into this catalog is very important for antimicrobials, especially injection-type antimicrobialsfrom the National Health and Care Commission issued the second and third-level hospital public hospital performance appraisal operation manual (2020 version), also mentioned the use of antimicrobial requirements the National Third-Level Public Hospital Performance Assessment Operation Manual (2020) requires that tertiary hospitals count "Antimicrobial Drug Use Strength (DDDs)": the National Second Level Public Hospital Performance Evaluation Manual (2020) also requires Second-level hospitals to statistics "antibacterial drug use strength (DDDs):
experts to Seibrand said that the current clinical problem is the biggest, in fact, is not the proportion of drugs, but reasonable drug use, the phenomenon of misuse of "God medicine" is too serious For example, some pharmaceutical companies in the promotion process will be short half-life, for the urgent and severe anti-bacterial drugs, pushed into a broad spectrum antibacterial "god medicine", resulting in the indiscriminate use of antimicrobial drugs, abuse of the situation Under the new performance appraisal, some falsely advertised broad-spectrum antibacterial drugs, hospital medication will be obviously limited industry generally believes that, compared with the simple drug proportion assessment, the current hospital performance assessment can effectively promote rational drug use, more able to control those known as "golden oil" "god medicine."